Virus News and Research

Latest Virus News and Research

Possible role for BK virus in development of prostate cancer

Now, new research by scientists at the University of Michigan Medical School suggests the intriguing possibility that this common virus also may play a role in prostate cancer – the second-leading cause of deaths from cancer in American men.

9 Aug 2004

Gravity model applicable to disease spread

Tracking the spread of new or re-emergent diseases such as SARS or smallpox is essential in controlling disease epidemics, but horse-and-buggy concepts of how diseases spread have been supplanted by 21st-century realities.

9 Aug 2004

Significant advance in the understanding of the hepatitis C virus (HCV)

Researchers have made a significant advance in the understanding of the hepatitis C virus (HCV) by identifying new genetic factors associated with clearing the virus spontaneously without the necessity for additional treatment.

9 Aug 2004

Correlation between HCV viral load and severity of liver disease

The significance of hepatitis C virus (HCV) serum titers (HCV viral load) has been examined in several clinical situations. There is much evidence that patients with a lower viral load have better response rates to anti-viral therapy compared to those with higher levels.

9 Aug 2004

Bush administration is depriving millions access to life-saving generic drugs

AIDS Healthcare Foundation, has commended the World Health Organization (WHO) for their leadership and sincere interest in ensuring the safety of generic HIV/AIDS drugs in the developing world.

6 Aug 2004

Ontario's first probable human case of West Nile virus

Dr. Sheela Basrur, Ontario's Chief Medical Officer of Health and Dr. Allen Heimann, Medical Officer of Health for Windsor-Essex County confirmed Ontario's first probable human case of West Nile virus in the Windsor-Essex area.

6 Aug 2004

Australian university signs multi-million dollar anti-cancer research deal

Australia's University of Newcastle Research Associates (TUNRA) Ltd has signed a licensing agreement worth approximately $10 million with the biotechnology company Psiron Ltd to develop anti-cancer treatments.

5 Aug 2004

Self-recovery from Hep C infection linked to genes that suppress action of killer immune cells

In a study to be published in Science online Aug. 6, researchers at Johns Hopkins have found that genes involved in suppressing the body's defensive "killer" immune cells are a potential key factor in spontaneous recovery from hepatitis C.

5 Aug 2004

New gene-silencing technique

A new gene-silencing technique that takes place in the nucleus of human cells, has been demonstrated by researchers at the University of California, San Diego (UCSD) School of Medicine and the VA San Diego Healthcare System.

5 Aug 2004

Approval of an injectable filler to correct facial fat loss in people with HIV/AIDS

The Food and Drug Administration has approved an injectable filler to correct facial fat loss in people with human immunodeficiency virus (HIV) infection.

5 Aug 2004

Protein loss plays role in acute T-cell leukemia

The loss of a key protein (Smad3) in a pathway that helps prevent tumors from forming is specific to one form of childhood leukemia, but not to other pediatric and adult forms of leukemia, according to a new study published in the August 5, 2004, New England Journal of Medicine.

5 Aug 2004

Mothers who catch a flu during pregnancy may increase the risk of their child developing schizophrenia

Schizophrenia is a chronic, severe, and disabling brain disease. Approximately 1 percent of the population develops schizophrenia during their lifetime — more than 2 million Americans suffer from the illness in a given year.

3 Aug 2004

New gene therapy treatment involves injecting Herpes simplex virus into the brain tumours of Glioma patients

Experts on the Gene Therapy Advisory Committee have given the go ahead for a large clinical trial of a new treatment for patients with Glioma - one of the most aggressive types of brain tumours for which there is currently no cure.

3 Aug 2004

Aventis ships its influenza vaccine, Fluzone

Aventis began to ship its influenza vaccine (Fluzone(R), Influenza Virus Vaccine) today, meeting the company's goal to provide Fluzone vaccine to customers to allow health-care providers to plan successful immunization programs for the upcoming influenza season.

3 Aug 2004

Metabasis Therapeutics announces multi-center Phase 2 study to evaluate the orally administered antiviral compound remofovir mesylate

Metabasis Therapeutics has announced the initiation of a multi-center, multi- national Phase 2 study to evaluate the orally administered antiviral compound remofovir mesylate in chronic hepatitis B (HBV) infected patients.

3 Aug 2004

Smart gene therapy might effectively prevent the organ damage commonly suffered by heart attack victims

Early intervention with a novel kind of "smart gene therapy" might effectively prevent the organ damage commonly suffered by heart attack victims, suggests a new animal study by researchers at Brigham and Women's Hospital in Boston and Duke University Medical Center.

2 Aug 2004

Computer-aided detection (CAD) can help physicians locate and analyze images from computed tomography (CT) scans

The diagnostic imaging modality of computed tomography (CT) scan is very helpful in lung cancer assessment as it spots even small lung tumors that might go undetected in conventional chest X-ray and other tests.

2 Aug 2004

A protein that the body uses to attack the AIDS virus is actually a stealthy defense mechanism that evolved 32 million years before HIV

A protein that the body uses to attack the AIDS virus is actually a stealthy defense mechanism that evolved 32 million years before the emergence of HIV, according to new findings from Fred Hutchinson Cancer Research Center.

2 Aug 2004

Determining the age of female mosquitoes may be crucial to halting the spread of diseases like malaria

A recent project at The Queensland Institute of Medical Research, Australia found that determining the age of female mosquitoes may be crucial to halting the spread of diseases like malaria that kill 2 million people annually.

2 Aug 2004

Researchers have secured more than $19.4 million for their work on cardiovascular and liver diseases and HIV/AIDS

Sydney University medical researchers have secured more than $19.4 million for their work on cardiovascular and liver diseases and HIV/AIDS in the latest round of National Health and Medical Research Council program grants.

2 Aug 2004

Virus News and Research

Latest Virus News and Research

Possible role for BK virus in development of prostate cancer

Gravity model applicable to disease spread

Significant advance in the understanding of the hepatitis C virus (HCV)

Correlation between HCV viral load and severity of liver disease

Bush administration is depriving millions access to life-saving generic drugs

Ontario's first probable human case of West Nile virus

Australian university signs multi-million dollar anti-cancer research deal

Self-recovery from Hep C infection linked to genes that suppress action of killer immune cells

New gene-silencing technique

Approval of an injectable filler to correct facial fat loss in people with HIV/AIDS

Protein loss plays role in acute T-cell leukemia

Mothers who catch a flu during pregnancy may increase the risk of their child developing schizophrenia

New gene therapy treatment involves injecting Herpes simplex virus into the brain tumours of Glioma patients

Aventis ships its influenza vaccine, Fluzone

Metabasis Therapeutics announces multi-center Phase 2 study to evaluate the orally administered antiviral compound remofovir mesylate

Smart gene therapy might effectively prevent the organ damage commonly suffered by heart attack victims

Computer-aided detection (CAD) can help physicians locate and analyze images from computed tomography (CT) scans

A protein that the body uses to attack the AIDS virus is actually a stealthy defense mechanism that evolved 32 million years before HIV

Determining the age of female mosquitoes may be crucial to halting the spread of diseases like malaria

Researchers have secured more than $19.4 million for their work on cardiovascular and liver diseases and HIV/AIDS

A new way of characterising biomolecules eBook

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Newsletters you may be interested in